Early T cell differentiation lessons from T-cell acute lymphoblastic leukemia

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• T cells originate from hematopoietic stem cells (HSC) and differentiate in the thymus, a process regulated by the thymic stroma and pre-T cell receptor (pre-TCR).
• T-cell acute lymphoblastic leukemia (T-ALL) arises when these normal developmental pathways are disrupted.
• Over 70% of T-ALL cases involve chromosomal rearrangements activating oncogenic transcription factors, primarily from the bHLH, HOX, and c-MYB families.

Purpose of the Study:

• To elucidate the role of oncogenic transcription factors and genetic lesions in T-ALL pathogenesis.
• To understand how these factors disrupt normal thymocyte development and promote self-renewal.
• To identify critical regulatory pathways and checkpoints involved in T-ALL development.

Main Methods:

• Analysis of chromosomal rearrangements in T-ALL.
• Investigation of oncogenic transcription factor families (bHLH, HOX, c-MYB).
• Examination of signaling pathways including NOTCH1 and pre-TCR, and mutations in CDKN2A and PTEN.

Main Results:

• Oncogenic transcription factors, such as bHLH proteins, inhibit tumor suppressors like E2A and HEB.
• Constitutive NOTCH1 signaling, pre-TCR activation, and loss-of-function mutations (CDKN2A, PTEN) are crucial for T-ALL induction.
• Specific oncogenic transcription factors (HOXA9, c-MYB, SCL, LYL-1) are implicated in HSC self-renewal.

Conclusions:

• Genetic lesions in T-ALL alter critical regulatory processes, promoting uncontrolled self-renewal.
• These alterations subvert normal thymocyte homeostasis, leading to leukemia development.
• Understanding these mechanisms provides insights into T-ALL pathogenesis and potential therapeutic targets.